LifeScience Clinical & Diagnostic

Ochre Bio and GSK Enter Multi-Year Partnership to Advance Liver Disease Research

Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The part...

 June 13, 2024 | News

GC Biopharma and Novel Pharma Receive FDA Fast Track Designation for Sanfilippo Syndrome Treatment GC1130A

GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has granted Fast Track Designation for their jointly developed MPSIIIA (Sanfili...

 June 11, 2024 | News

Gilead and Kite Oncology Announce Approval of Yescarta® for Early Treatment of DLBCL in Singapore

    **-- In ZUMA-7, Yescarta Patients with DLBCL were 2.5 Times More Likely than SOC to be Alive at Two Years Without Cancer Progression or Nee...

 June 10, 2024 | News

EnGeneIC and Singapore Institute of Advanced Medicine Partner to Transform Cancer Treatment in Asia

EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has  announce...

 June 07, 2024 | News

SK Telecom Launches AI-Based Veterinary X-Ray Service 'X Caliber' in Australia

In collaboration with ATX Medical Solutions, SKT launches X Caliber in Australia, which has one of the highest rates of pet ownership in the world ...

 May 29, 2024 | News

Innovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to SevereInnovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to Severe Plaque Psoriasis

Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of canc...

 May 28, 2024 | News

 Guardant Health’s Shield™ Blood Test for Colorectal Cancer Screening Recommended for FDA Approval

    Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the Molecular and Clinical Genetics Panel of...

 May 27, 2024 | News

Aptamer Group Signs £465,000 Agreement for Development of Cervical Cancer Blood Test

Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...

 May 22, 2024 | News

RemeGen Announces Completion of Patient Enrollment for Two Phase III Clinical Trials of Telitacicept in China

RemeGen Co. a commercial-stage biotechnology company, recently announced significant progress of Telitacicept (RC18), that two Phase III clinical tria...

 May 22, 2024 | News

AstraZeneca Announces $1.5 Billion Manufacturing Facility in Singapore for Cutting-Edge Cancer Treatments

  AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global s...

 May 20, 2024 | News

Serum Institute of India Acquires 20% Stake in IntegriMedical to Accelerate Development of Needle-Free Injection Technology

-       With this investment, SII will acquire 20% stake in IntegriMedical   -      ...

 May 20, 2024 | News

Amplexd Therapeutics Secures $2 Million in Strategic Funding to Advance Non-Invasive Treatments for HPV-Induced Cervical Precancers

Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in acc...

 May 20, 2024 | News

Amgen's IMDELLTRA™ Approved for Aggressive Lung Cancer

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with e...

 May 17, 2024 | News

A&D Invests $1M in Aevice Health to Expand Remote Respiratory Solutions

A&D Company, Limited has entered into a US$1M investment agreement with  Aevice Health  The collaboration is geared towards jointly expand...

 May 15, 2024 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in